Related references
Note: Only part of the references are listed.Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
Guido Bocci et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG
C. H. Smorenburg et al.
ANNALS OF ONCOLOGY (2014)
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study
M. E. Cazzaniga et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2014)
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
Evangelos Briasoulis et al.
BMC CANCER (2013)
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
Evangelos Briasoulis et al.
CLINICAL CANCER RESEARCH (2009)
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women
E Bajetta et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Capecitabine and vinorelbine in elderly patients (≥65 years) with metastatic breast cancer:: a phase I trial (SAKK 25/99)
D Hess et al.
ANNALS OF ONCOLOGY (2004)
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
M Colleoni et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
